Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161747906> ?p ?o ?g. }
- W2161747906 endingPage "67" @default.
- W2161747906 startingPage "61iii" @default.
- W2161747906 abstract "There is currently no universal consensus on nomenclature for spondyloarthropathy (SpA), or on activity and severity criteria for ankylosing spondylitis (AS).Points of agreement and majority opinions among 28 international experts in the field were identified by questionnaire. Agreement was defined as >80% concurrence, clear majority as >60% concurrence, and a majority or trend as >50% concurrence.Respondents agreed on the need for one term that reflects the inflammatory nature of the disease, but no agreement was reached on a specific term. Agreement included subdivision of patients with SpA into AS, psoriatic arthritis, inflammatory bowel disease associated arthritis, and undifferentiated spondyloarthritis/spondyloarthropathy. A majority of experts defined active disease as fulfilling classification criteria for AS and/or a SpA, and disease activity measured by a Bath AS Disease Activity Index (BASDAI) score >4 determined by two patient visits during a two month period, but no maximum radiographic score. The majority of participants considered failure of treatment response to non-steroidal anti-inflammatory drugs (NSAIDs) alone to be a prerequisite for active/severe AS, and 15/28 (54%) thought that NSAID treatment failure should be defined as lack of response to two or more NSAIDs.Respondents agreed that a two to five year study is the ethical method to demonstrate effects of anti-tumour necrosis factor alpha (TNFalpha) therapy on radiographic progression of AS, and that inclusion criteria should include a certain level of disease activity (measured by BASDAI) and failure of certain treatments. After the efficacy of anti-TNFalpha therapy in AS and psoriatic arthritis is proved, respondents agreed that more studies will be needed to show efficacy for other SpA subsets." @default.
- W2161747906 created "2016-06-24" @default.
- W2161747906 creator A5064493310 @default.
- W2161747906 creator A5085745432 @default.
- W2161747906 date "2002-11-01" @default.
- W2161747906 modified "2023-10-12" @default.
- W2161747906 title "Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002" @default.
- W2161747906 cites W1965212418 @default.
- W2161747906 cites W1966756689 @default.
- W2161747906 cites W1974903457 @default.
- W2161747906 cites W1999404885 @default.
- W2161747906 cites W2022917163 @default.
- W2161747906 cites W2025464279 @default.
- W2161747906 cites W2026258433 @default.
- W2161747906 cites W2035612894 @default.
- W2161747906 cites W2037976962 @default.
- W2161747906 cites W2039846822 @default.
- W2161747906 cites W2040475721 @default.
- W2161747906 cites W2079589808 @default.
- W2161747906 cites W2085135652 @default.
- W2161747906 cites W2085267090 @default.
- W2161747906 cites W2103778140 @default.
- W2161747906 cites W2140235660 @default.
- W2161747906 cites W2160367898 @default.
- W2161747906 cites W2162109294 @default.
- W2161747906 cites W2163200710 @default.
- W2161747906 cites W2164216207 @default.
- W2161747906 cites W2167467847 @default.
- W2161747906 cites W2171346871 @default.
- W2161747906 cites W2408784888 @default.
- W2161747906 cites W2418885747 @default.
- W2161747906 cites W2467634308 @default.
- W2161747906 cites W303553237 @default.
- W2161747906 cites W35214484 @default.
- W2161747906 cites W55471147 @default.
- W2161747906 doi "https://doi.org/10.1136/ard.61.suppl_3.iii61" @default.
- W2161747906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1766727" @default.
- W2161747906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12381512" @default.
- W2161747906 hasPublicationYear "2002" @default.
- W2161747906 type Work @default.
- W2161747906 sameAs 2161747906 @default.
- W2161747906 citedByCount "31" @default.
- W2161747906 countsByYear W21617479062012 @default.
- W2161747906 countsByYear W21617479062013 @default.
- W2161747906 countsByYear W21617479062014 @default.
- W2161747906 countsByYear W21617479062016 @default.
- W2161747906 countsByYear W21617479062019 @default.
- W2161747906 countsByYear W21617479062020 @default.
- W2161747906 countsByYear W21617479062021 @default.
- W2161747906 countsByYear W21617479062022 @default.
- W2161747906 crossrefType "journal-article" @default.
- W2161747906 hasAuthorship W2161747906A5064493310 @default.
- W2161747906 hasAuthorship W2161747906A5085745432 @default.
- W2161747906 hasBestOaLocation W21617479061 @default.
- W2161747906 hasConcept C126322002 @default.
- W2161747906 hasConcept C1862650 @default.
- W2161747906 hasConcept C2776260265 @default.
- W2161747906 hasConcept C2776661782 @default.
- W2161747906 hasConcept C2777138892 @default.
- W2161747906 hasConcept C2777226972 @default.
- W2161747906 hasConcept C2777402515 @default.
- W2161747906 hasConcept C2777453003 @default.
- W2161747906 hasConcept C2777575956 @default.
- W2161747906 hasConcept C2778579456 @default.
- W2161747906 hasConcept C2779134260 @default.
- W2161747906 hasConcept C2779650986 @default.
- W2161747906 hasConcept C2780131103 @default.
- W2161747906 hasConcept C2780132546 @default.
- W2161747906 hasConcept C71924100 @default.
- W2161747906 hasConceptScore W2161747906C126322002 @default.
- W2161747906 hasConceptScore W2161747906C1862650 @default.
- W2161747906 hasConceptScore W2161747906C2776260265 @default.
- W2161747906 hasConceptScore W2161747906C2776661782 @default.
- W2161747906 hasConceptScore W2161747906C2777138892 @default.
- W2161747906 hasConceptScore W2161747906C2777226972 @default.
- W2161747906 hasConceptScore W2161747906C2777402515 @default.
- W2161747906 hasConceptScore W2161747906C2777453003 @default.
- W2161747906 hasConceptScore W2161747906C2777575956 @default.
- W2161747906 hasConceptScore W2161747906C2778579456 @default.
- W2161747906 hasConceptScore W2161747906C2779134260 @default.
- W2161747906 hasConceptScore W2161747906C2779650986 @default.
- W2161747906 hasConceptScore W2161747906C2780131103 @default.
- W2161747906 hasConceptScore W2161747906C2780132546 @default.
- W2161747906 hasConceptScore W2161747906C71924100 @default.
- W2161747906 hasIssue "Supplement 3" @default.
- W2161747906 hasLocation W21617479061 @default.
- W2161747906 hasLocation W21617479062 @default.
- W2161747906 hasLocation W21617479063 @default.
- W2161747906 hasLocation W21617479064 @default.
- W2161747906 hasOpenAccess W2161747906 @default.
- W2161747906 hasPrimaryLocation W21617479061 @default.
- W2161747906 hasRelatedWork W1002025606 @default.
- W2161747906 hasRelatedWork W2052036197 @default.
- W2161747906 hasRelatedWork W2072412214 @default.
- W2161747906 hasRelatedWork W2103612449 @default.
- W2161747906 hasRelatedWork W2109095647 @default.
- W2161747906 hasRelatedWork W2142312793 @default.
- W2161747906 hasRelatedWork W2170845561 @default.